We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines to prevent and treat disease.
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous approved treatments and product candidates in development.
Sony Europe BV is dedicated to helping the scientific community, researchers, laboratory professionals, and institutions achieve the best scientific results possible. By leveraging Sony’s comprehensive expertise in electronics innovation and design and with our technological assets we are accelerating development of next-generation cell analysis systems. We bring a unique perspective to science’s high-level instrumentation and are creating innovative products to address our customer’s challenges.
The ILC5 conference will provide a perfect opportunity to discuss the latest developments in the field from fundamental discoveries to translational studies and we look forward to establishing partnerships with the industry to support the delivery of this key international event.
We look forward to working with you to maximise the return on your investment and create a successful package to meet your organisation’s objectives and budget.